Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 2
1954 2
1955 6
1956 2
1957 2
1958 6
1959 2
1960 6
1961 9
1962 7
1963 9
1964 12
1965 16
1966 23
1967 22
1968 17
1969 13
1970 15
1971 10
1972 12
1973 6
1974 12
1975 12
1976 21
1977 13
1978 6
1979 29
1980 20
1981 28
1982 20
1983 39
1984 29
1985 47
1986 41
1987 35
1988 50
1989 49
1990 66
1991 50
1992 81
1993 56
1994 66
1995 71
1996 68
1997 78
1998 98
1999 101
2000 111
2001 108
2002 112
2003 135
2004 124
2005 140
2006 140
2007 145
2008 151
2009 167
2010 174
2011 152
2012 209
2013 216
2014 205
2015 222
2016 200
2017 226
2018 229
2019 261
2020 332
2021 392
2022 360
2023 280
2024 310
2025 363
2026 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,258 results

Results by year

Filters applied: . Clear all
Page 1
Juvenile Idiopathic Arthritis.
Sandborg CI, Schulert GS, Kimura Y. Sandborg CI, et al. Among authors: kimura y. N Engl J Med. 2025 Jul 10;393(2):162-174. doi: 10.1056/NEJMra2402073. N Engl J Med. 2025. PMID: 40632950 Review. No abstract available.
Authors' response.
Murai Y, Koya T, Koda H, Uji W, Tanaka M, Endo M, Oshima K, Matsuda T, Ueno H, Aoki A, Shima K, Kimura Y, Kikuchi T. Murai Y, et al. Among authors: kimura y. Ann Allergy Asthma Immunol. 2025 Oct;135(4):459. doi: 10.1016/j.anai.2025.06.030. Ann Allergy Asthma Immunol. 2025. PMID: 41038660 No abstract available.
Systemic increase of AMPA receptors associated with cognitive impairment of long COVID.
Fujimoto Y, Abe H, Eiro T, Tsugawa S, Tanaka M, Hatano M, Nakajima W, Ichijo S, Arisawa T, Takada Y, Kimura K, Sano A, Hirahata K, Sasaki N, Kimura Y, Takahashi T. Fujimoto Y, et al. Among authors: kimura y. Brain Commun. 2025 Oct 1;7(5):fcaf337. doi: 10.1093/braincomms/fcaf337. eCollection 2025. Brain Commun. 2025. PMID: 41036177 Free PMC article.
Internal cap-initiated translation for efficient protein production from circular mRNA.
Fukuchi K, Nakashima Y, Abe N, Kimura S, Hashiya F, Shichino Y, Liu Y, Ogisu R, Sugiyama S, Kawaguchi D, Inagaki M, Meng Z, Kajihara S, Tada M, Uchida S, Li TT, Maity R, Kawasaki T, Kimura Y, Iwasaki S, Abe H. Fukuchi K, et al. Among authors: kimura y. Nat Biotechnol. 2026 Jan;44(1):120-132. doi: 10.1038/s41587-025-02561-8. Epub 2025 Feb 19. Nat Biotechnol. 2026. PMID: 39972222
Mortality in chronic pulmonary aspergillosis: a systematic review and individual patient data meta-analysis.
Sengupta A, Ray A, Upadhyay AD, Izumikawa K, Tashiro M, Kimura Y, Bongomin F, Su X, Maitre T, Cadranel J, de Oliveira VF, Iqbal N, Irfan M, Uzunhan Y, Aguilar-Company J, Munteanu O, Beardsley J, Furuuchi K, Takazono T, Ito A, Kosmidis C, Denning DW. Sengupta A, et al. Among authors: kimura y. Lancet Infect Dis. 2025 Mar;25(3):312-324. doi: 10.1016/S1473-3099(24)00567-X. Epub 2024 Nov 29. Lancet Infect Dis. 2025. PMID: 39617023 Free article.
Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.
Sasaki W, Saito R, Suzuki K, Watanabe D, Minami-Hori M, Kamada H, Amano H, Uchiyama A, Motegi SI, Kamura M, Sugita K, Kubota N, Nomura T, Ozawa M, Takahashi T, Yamakita T, Sugiura K, Ikegami T, Igawa K, Kimura Y, Kataoka Y, Kamide R, Takahashi M, Tanaka A, Sugawara-Mikami M. Sasaki W, et al. Among authors: kimura y. J Dermatol. 2025 Jul 23. doi: 10.1111/1346-8138.17877. Online ahead of print. J Dermatol. 2025. PMID: 40698830
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for advanced nonsquamous non-small cell lung cancer with impaired renal function: A multicenter, single-arm phase 2 trial (RESTART, LOGiK 2002).
Shiraishi Y, Shimose T, Tobino K, Toi Y, Wakuda K, Matsumoto H, Sakaguchi T, Mashimoto A, Hayashi H, Ebina-Shibuya R, Mori M, Taniguchi Y, Kuyama S, Kashiwabara K, Furuyama K, Yoshimine K, Kimura Y, Kobayashi H, Kishimoto J, Okamoto I. Shiraishi Y, et al. Among authors: kimura y. Lung Cancer. 2025 May;203:108543. doi: 10.1016/j.lungcan.2025.108543. Epub 2025 Apr 18. Lung Cancer. 2025. PMID: 40253945 Free article. Clinical Trial.
6,258 results